Hendershot Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.26M Sell
2,453
-2
-0.1% -$2.03K 0.3% 43
2025
Q4
$2.64M Sell
2,455
-85
-3% -$81.3K 0.34% 42
2025
Q3
$1.94M Hold
2,540
0.24% 47
2025
Q2
$1.98M Sell
2,540
-218
-8% -$169K 0.26% 47
2025
Q1
$2.28M Buy
2,758
+228
+9% +$190K 0.31% 46
2024
Q4
$1.95M Sell
2,530
-60
-2% -$49.7K 0.27% 47
2024
Q3
$2.29M Sell
2,590
-46
-2% -$41.4K 0.31% 45
2024
Q2
$2.39M Sell
2,636
-96
-4% -$76.8K 0.34% 45
2024
Q1
$2.13M Sell
2,732
-130
-5% -$92.5K 0.3% 48
2023
Q4
$1.67M Sell
2,862
-33
-1% -$19.3K 0.26% 51
2023
Q3
$1.56M Sell
2,895
-155
-5% -$79.9K 0.26% 52
2023
Q2
$1.43M Sell
3,050
-139
-4% -$58.3K 0.23% 52
2023
Q1
$1.1M Sell
3,189
-333
-9% -$112K 0.18% 61
2022
Q4
$1.29M Hold
3,522
0.22% 60
2022
Q3
$1.14M Sell
3,522
-178
-5% -$56.4K 0.21% 66
2022
Q2
$1.2M Sell
3,700
-50
-1% -$15K 0.21% 68
2022
Q1
$1.07M Sell
3,750
-448
-11% -$115K 0.16% 73
2021
Q4
$1.16M Buy
+4,198
New +$1.06M 0.18% 73

Other funds holding LLY

Hendershot Investments's LLY Position: Q1 2026 in Review

Hendershot Investments reduced its Eli Lilly (LLY) stake by 0.08% in Q1 2026, selling an estimated $2.03K and leaving 2,453 shares worth $2.26M. The position accounts for 0.3% of the portfolio, ranked #43.

Hendershot Investments first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.64M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hendershot Investments held 2,453 shares of Eli Lilly worth $2.26M as of Q1 2026.
  • Hendershot Investments sold 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
  • Eli Lilly made up 0.3% of Hendershot Investments's portfolio in Q1 2026, its #43 holding.
  • Hendershot Investments first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Hendershot Investments's Eli Lilly position peaked at $2.64M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hendershot Investments's 13F filing for Q1 2026, filed 27 Apr 2026.